![International Journal of Translational Research-Pharmacogenetics-Tarek Magdy Mohamed](https://jphi-healthcarejournals.net/uploads/1678520909_d61ed70fc126fdd3f3d9.jpg)
USA
Louisiana State University Health Sciences Center Shreveport · Department of Pathology
Tarek Magdy Mohamed
Address:
Shreveport, USA
Research Interests:
- Clinical Pharmacy
- Pharmaceutical Development
- Pharmaceutics and Pharmaceutical Technology
- Drug Information
- Pharmacokinetics
- Medical Pharmacology
- Clinical Trials of Pharmaceuticals
- Pharmacogenetics
- Human Genetics
- Pharmacogenomics
Publications:
- Abstract P3109: Identification Of Drug Transporter Genomic Variants And Inhibitors That Protect Against Doxorubicin Induced Cardiotoxicity
- Prime time for doxorubicin-induced cardiotoxicity genetic testing
- Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity
- RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy
- Targeting OCT3 attenuates doxorubicin-induced cardiac injury